Benuvia Therapeutics Inc. is focused on financing and developing low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases. We have a broad pipeline of clinical stage product candidates targeting rare and underserved diseases. Our pipeline is based on nearly a decade of clinical research across a dozen clinical studies. We seek partners to support the future development of these candidate assets through the 505(b)2 pathway. Further information is available at www.benuvia.com.
View Top Employees from Benuvia Therapeutics Inc.Website | http://www.benuvia.com |
Revenue | $7 million |
Funding | $350000 |
Employees | 10 (10 on RocketReach) |
Founded | 2019 |
Address | 444 South Ellis Street, Chandler, Arizona 85224, US |
Phone | (480) 581-1385 |
Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Biotechnology, Pharmaceuticals, Healthcare |
SIC | SIC Code 80 Companies, SIC Code 804 Companies |
NAICS | NAICS Code 62 Companies, NAICS Code 6213 Companies, NAICS Code 621399 Companies, NAICS Code 621 Companies, NAICS Code 62139 Companies |
Looking for a particular Benuvia Therapeutics Inc. employee's phone or email?
The Benuvia Therapeutics Inc. annual revenue was $7 million in 2024.
Bill Langlois is the Director of Trade of Benuvia Therapeutics Inc..
10 people are employed at Benuvia Therapeutics Inc..
Benuvia Therapeutics Inc. is based in Chandler, Arizona.
The NAICS codes for Benuvia Therapeutics Inc. are [62, 6213, 621399, 621, 62139].
The SIC codes for Benuvia Therapeutics Inc. are [80, 804].